Hepatitis Delta in Focus: Episode 3 of Answering the Questions on Screening, Diagnosis, and Treatment
In this podcast episode, listen to expert faculty perspectives on HDV management, including their approach to complex clinical cases, staging liver disease, and screening for hepatocellular carcinoma.
Decera Clinical Education Infectious Disease Podcast · Nancy Reau MD, Heiner Wedemeyer MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Nancy Reau, MD, and Heiner Wedemeyer, MD, provide expert insight on HDV management, including:
- Use of noninvasive imaging or biopsy for staging liver disease
- Screening for hepatocellular carcinoma
- HBV treatment
- Role of comedications (eg, erythropoietin, eltrombopag)
- Approach to complex cases, such as patients with:
- Significant fibrosis and low HDV RNA levels
- Hepatitis delta antibody positivity, but HDV RNA negativity
- HIV coinfection
- Decompensated or recently decompensated cirrhosis
Faculty:
Nancy Reau, MD
Professor of Medicine
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Richard B. Capps Chair of Hepatology
Rush University Medical Center
Chicago, Illinois
Heiner Wedemeyer, MD
Professor and Chairman
Department of Gastroenterology, Hepatology and Endocrinology
Hannover Medical School
Hannover, Germany
Link to full program:
http://bit.ly/3yp1Lxf
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.